Advisory Board and Editors Cell Biology
Raphaël Lévy
PhD, physics, Strasbourg, France, 2002, polymer adsorption with the Atomic Force Microscope
Post-doctoral fellowship, Liverpool, UK, Design of peptides as capping agents for gold nanoparticles
BBSRC David Phillips Fellow, Liverpool, 2006-11, Nanoparticle-based imaging in living cells; biomimetic nanoparticles
2011- Lecturer, then Senior Lecturer, University of Liverpool
Our research focuses on nanoparticles, their structure, and applications, in particular for biological imaging both at the single molecule level and for cell tracking in animal models.
Zhiming Li
Dr. Zhiming Li is an early career researcher at Columbia University. His primary research focus is on epigenetic inheritance and cancer epigenetics, and his long-term goals are to understand the fundamental mechanisms of epigenetic inheritance and how such mechanisms and epigenetic alterations are involved in tumorigenesis, which eventually would allow him to identify druggable targets for cancer intervention.
Xing Li
Dr. Xing Li is an Assistant Professor and Associate Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic - voted the best hospital by U.S. News & World Report. Dr. Li completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor, Michigan, USA. Dr. Li also holds a Masters Degree in Biochemistry and Molecular Biology and Bachelors Degree in Microbiology. Dr. Li’s research interests focus on machine learning, bioinformatics, and statistical data mining in large scale data in biomedical research, such as next generation sequencing data (whole genome sequencing, RNA-seq, microarray data), in the file. He has published more than 20 peer-reviewed papers in reputable journals and book chapters in the fields of Bioinformatics and Biostatistics, cancer research, cardiovascular disease, embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) research, and human genomics, genetics and development, and Microbiology. Dr. Li’s publications have been highlighted as Journal Cover Stories, Journal Featured Articles, Highlights Section Papers, Must Read by Faculty 1000, and ESC & iPSC News, etc. Dr. Li has been developing data analysis tools, such as RCircle and PCA3d, etc. Dr. Li is also a member of American Association for Cancer Research (AACR), International Society for Computational Biology (ISCB), American Statistics Association (ASA) and American Heart Association (AHA).
Ning Li
Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.
Jiaqi Liang
Dr. Jiaqi Liang is a Researcher in the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University. Her research predominantly focuses on the clinical and molecular research of lung cancer.
Feng Liu
Feng Liu received his Ph.D. degree from the School of Life Science and Technology, University of Electronic Science and Technology of China and went on to work in the Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, China. Now he is a professor and his current research interests include Brain and Cognition, Magnetic Resonance Imaging, Imaging Genetic and Multivariate Pattern Analysis.
Current research focuses on investigating the impact of the environmental factors (e.g., green space, PM2.5, etc) on human brain measured by magnetic resonance imaging.
Homepage: https://fengliu001.github.io/
Dongliang Liu
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.
Alexandra Lusser
Associate Professor at the Medical University of Innsbruck, Austria. Our work includes the study of chromatin modulating factors in Drosophila and mouse and the analysis of posttranscriptional modifications on RNA.
Shuangtao Ma
Assistant Professor of Medicine
Michigan State University
Emiliano Maiani
Emiliano Maiani earned his MS and PhD in Molecular and Cellular Biology at the University of Rome “Tor Vergata”, Rome, Italy. In 2013, he joined the Cell Stress and Survival laboratory headed by prof. Francesco Cecconi at the Danish Cancer Society Research Center (DCRC), Copenhagen, Denmark. At the end of 2017, he moved for a second postdoc at the Computational Biology Laboratory headed by Elena Papaleo at the DCRC, Copenhagen. In this period, he expanded his knowledge to computational and structural biology. His research is focused on cancer biology and in particular in autophagy and DNA damage response pathways.
Safarina G Malik
Safarina G. Malik is a Principal Investigator at the Genome Diversity and Disease Division of the Mochtar Riady Institute for Nanotechnology, Tangerang, Banten, Indonesia, since January 2022. From 2011 to 2021 she lead the Lifestyle Diseases Research Group at the Eijkman Institute for Molecular Biology, Jakarta, Indonesia. Her key research topics and expertise include genetic diversity, microbiome, mitochondrial genetics and dysfunction, medical genetics, lifestyle disease association, nutrigenetics-nutrigenomics, population genetics and evolution.